These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25182650)

  • 1. Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus.
    Cheng M; Huang JX; Ramu S; Butler MS; Cooper MA
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6819-27. PubMed ID: 25182650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of ramoplanin-resistant Staphylococcus aureus.
    Schmidt JW; Greenough A; Burns M; Luteran AE; McCafferty DG
    FEMS Microbiol Lett; 2010 Sep; 310(2):104-11. PubMed ID: 20659164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Brumfitt W; Salton MR; Hamilton-Miller JM
    J Antimicrob Chemother; 2002 Nov; 50(5):731-4. PubMed ID: 12407132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV; Dholakia N; Ho DH; LeBlanc B; Dvorak T; Streeter H
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin.
    Jabes D; Brunati C; Candiani G; Riva S; Romanó G; Maffioli S; Rossi R; Simone M; Gaspari E; Donadio S
    Antimicrob Agents Chemother; 2014; 58(4):1922-9. PubMed ID: 24419352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Lawrence T; Rotstein C; Beam TR; Gorzynski EA; Amsterdam D
    Antimicrob Agents Chemother; 1993 Apr; 37(4):896-900. PubMed ID: 8494388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of peptidoglycan biosynthesis by ramoplanin.
    Somner EA; Reynolds PE
    Antimicrob Agents Chemother; 1990 Mar; 34(3):413-9. PubMed ID: 2334153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface.
    Hamburger JB; Hoertz AJ; Lee A; Senturia RJ; McCafferty DG; Loll PJ
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13759-64. PubMed ID: 19666597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D; Mildvan D; Handwerger S
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent.
    Fulco P; Wenzel RP
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):939-45. PubMed ID: 17181409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM; Merriam CV; Tyrrell KL; Warren YA; Fernandez H; Goldstein EJ
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
    O'Hare MD; Felmingham D; Grüneberg RN
    J Chemother; 1989 Jul; 1(4 Suppl):210-1. PubMed ID: 16312373
    [No Abstract]   [Full Text] [Related]  

  • 17. Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.
    Boger DL
    Med Res Rev; 2001 Sep; 21(5):356-81. PubMed ID: 11579438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of the Ramoplanin Activity Analogue by Double Gene Inactivation.
    Han J; Chen J; Shao L; Zhang J; Dong X; Liu P; Chen D
    PLoS One; 2016; 11(5):e0154121. PubMed ID: 27149627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.
    Brumfitt W; Maple PA; Hamilton-Miller JM
    Drugs Exp Clin Res; 1990; 16(8):377-83. PubMed ID: 2097143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and biology of the ramoplanin family of peptide antibiotics.
    McCafferty DG; Cudic P; Frankel BA; Barkallah S; Kruger RG; Li W
    Biopolymers; 2002; 66(4):261-84. PubMed ID: 12491539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.